申请人:KRKA, D.D., Novo Mesto
公开号:EP2141236A1
公开(公告)日:2010-01-06
This invention relates to improved processes for the production of lipstatin and /or orlistat and means therefore. In particular, the invention relates to microorganisms characterized by abolished or reduced activity of the BKD complex, e.g. mutated branched-chain 2-oxo acid dehydrogenase (BKD) having reduced or abolished activity, nucleotide sequences suitable for achieving reduced or abolished BKD activity, and microorganisms having reduced or abolished BKD activity. The invention in particular relates to lipstatin-producing microorganisms of the genus Streptomyces. Furthermore, this invention relates to the use of these nucleotide sequences, microorganisms or BKD having reduced or abolished activity in the production of lipstatin and/or orlistat.
本发明涉及脂肪司他汀和/或奥利司他的改进生产工艺及其方法。特别是,本发明涉及以 BKD 复合物活性减弱或丧失为特征的微生物,例如,活性减弱或丧失的突变支链 2-氧代酸脱氢酶(BKD)、适用于实现 BKD 活性减弱或丧失的核苷酸序列以及 BKD 活性减弱或丧失的微生物。本发明尤其涉及链霉菌属的产脂素微生物。此外,本发明还涉及在生产脂司他丁和/或奥利司他中使用这些核苷酸序列、微生物或活性降低或消失的BKD。